IP Library Granted Patent US 11,623,027
Granted Patent B2
US 11,623,027 · App. 16/720,968 · Granted Apr 11, 2023

Partially resorbable implants and methods

Inventors: Bradley William Paddock (Ridgewood, NJ); Amir Ali Sharifi-Mehr (Bloomingdale, NJ); Adam Laurance Wollowick (New York, NY); Oliver Buchert (Franklin Lakes, NJ); Matthew B. Havener (West Conshohocken, PA); Robert Cipoletti (Pompton Plains, NJ); Steven Willis (Mahwah, NJ); Marc Gilles Long (Denville, NJ)
Assignee: Stryker European Operations Holdings LLC
A61L27/58A61F2/44A61F2/447A61F2/4465A61F2/4455A61F2002/3008A61F2002/30032A61F2002/30133A61F2002/30235A61F2002/30387A61F2002/30677A61F2002/30883A61F2002/30884A61F2002/30904A61F2002/4629A61F2002/4631A61L27/50A61L2430/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,623,027
App. No.
16/720,968
Granted
Apr 11, 2023
Kind
B2
Abstract

Implants including non-resorbable frameworks and resorbable components, as well as methods of use thereof are disclosed. The embodiments include different combinations of a non-resorbable framework (in some case structural and in other cases non-structural), and a resorbable component embedded within and/or around the framework (again, in some cases structural and in other cases non-structural). The disclosed implants provide an efficient means of providing structural support for the vertebral bodies post-implantation, as well as encouraging resorption of the implant and fusion of the associated vertebral bodies without negative side effects and/or failure, such as subsidence of the implant or cracking/fracturing of a portion of the implant when implanted.

Claims (11)

1. An implant sized and adapted for insertion into an intervertebral space between adjacent vertebral bodies comprising:

a non-structural, non-resorbable framework having a main body and a first fluid conduit within the main body, the main body having an injection port in fluid communication with the first fluid conduit;

a resorbable, structural component having top and bottom bone-contacting surfaces and an opening in at least one of the top and bottom surfaces, the opening being in fluid communication with the first fluid conduit, and

a second fluid conduit projecting outward from the main body and being fluidly connected with the first fluid conduit in the main body, wherein the outwardly-projecting second fluid conduit defines the opening in the at least one of the top and bottom surfaces of the resorbable, structural component.

2. An implant according to claim 1 , wherein the resorbable, structural component is a multi-piece component.

3. An implant according to claim 1 , wherein the resorbable, structural component surrounds the outwardly-projecting fluid conduit.

4. An implant according to claim 1 , wherein a vertical opening extends through the main body of the framework.

5. A method of using an implant comprising:

implanting an implant between adjacent vertebral bodies, the implant being sized and adapted for insertion into an intervertebral space between adjacent vertebral bodies, the implant comprising a non-structural, non-resorbable framework having a main body and a fluid conduit within the main body, the main body having an injection port in fluid communication with the fluid conduit, the implant including a resorbable, structural component having top and bottom bone-contacting surfaces and an opening in at least one of the top and bottom surfaces, the opening being in fluid communication with the fluid conduit, and

injecting a biologic material into the injection port so that the biologic material travels through the fluid conduit in the main body and out of the opening in the at least one of the top and bottom surfaces of the resorbable, structural component.

6. The method according to claim 5 , wherein the biologic material is selected from the group consisting of a bone cement, bone-growth promoting material, Bone Marrow Aspirate, antimicrobial material, bone morphogenic proteins (“BMP”), stem cells, solutions to assist in the resorption process, and tissue-targeted glycosaminoglycans.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2025
From: STRYKER EUROPEAN HOLDINGS I, LLC; STRYKER EUROPEAN OPERATIONS HOLDINGS LLC; STRYKER CORPORATION; STRYKER EUROPEAN OPERATIONS LIMITED; HOWMEDICA OSTEONICS CORP.
To: VB SPINE US OPCO LLC
Reel/Frame 073031/0754 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2025
From: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC
To: VB SPINE US OPCO LLC
Reel/Frame 072926/0763 →
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC
Reel/Frame 069730/0754 →
CHANGE OF NAME Recorded Mar 28, 2022
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC
Reel/Frame 059523/0895 →
NUNC PRO TUNC ASSIGNMENT Recorded Mar 25, 2022
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 059499/0810 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2020
From: PADDOCK, BRADLEY WILLIAM; SHARIFI-MEHR, AMIR ALI; WOLLOWICK, ADAM LAURANCE; BUCHERT, OLIVER; HAVENER, MATTHEW B.; CIPOLETTI, ROBERT; WILLIS, STEVEN; LONG, MARC GILLES
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 051626/0405 →